Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: An open study

Israel Medical Association Journal

Volumn 4, Issue 11 SUPPL., 2002, Pages 928-930

  Hamuryudan, Vedat ^a   Özyazgan, Yilmaz ^a   Fresko, Yzzet ^a   Mat, Cem ^a   Yurdakul, Sebahattin ^a   Yazici, Hasan ^a  

^a Veysipasa sokak   (Turkey)

Author keywords

Azathioprine; Beh et's syndrome; Interferon; Treatment; Uveitis

Indexed keywords

DISEASES; IMMUNOLOGY; MONITORING; TOXICITY;

IMMUNOSUPPRESSIVES;

PATIENT TREATMENT;

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PARACETAMOL; PREDNISOLONE; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; BEHCET DISEASE; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; EYE DISEASE; FLU LIKE SYNDROME; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MALE; MORBIDITY; PANCYTOPENIA; PATIENT MONITORING; PILOT STUDY; RETINA DISEASE; UVEITIS; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; AZATHIOPRINE; BEHCET SYNDROME; DRUG MONITORING; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; INTERFERON ALFA-2B; LEUKOPENIA; MALE; OPHTHALMOSCOPY; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036842714     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999;341:1284-91.
2. Yazici H. Behçet's syndrome: where do we stand? Am J Med 2002;112:75-6.
3. Yazici H, Yurdakul S, Hamuryudan V. The management of Behçet's syndrome: how are we doing? Clin Exp Rheumatol 1999;17:145-7.
4. Kaklamani VG, Kaklamanis PG. Treatment of Behçet's disease - an update. Semin Arthritis Rheum 2001;30:299-312.
5. Kotter I, Eckstein AK, Stubiger N, Zierhut M. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 1998;82:488-94.
6. Internatinal Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
7. Yazici H, Tüzün Y, Pazarli H, et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984;43:783-9.
8. Yazici H, Yurdakul S, Hamuryudan V. Behçet disease. Curr Opin Rheumatol 2001;13:18-22.
9. Stubiger N, Kotter I, Deuter C, Zierhut M. Behçet's disease: uveitis therapy with interferon alpha2a prospective therapy in 33 patients. Klin Monatsbl Augenheilkd 2001;218:767-73.
10. Wechsler B, Bodaghi B, Huong DL, et al. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease. Ocul Immunol Inflamm 2000;8:293-301.
11. Zouboulis CS, Orfanos CE. Treatment of Adamantiades-Behçet disease with interferon alfa. Arch Dermatol 1998;134:1910-16.